Literature DB >> 16194607

Adult bone marrow-derived stem cells and the injured heart: just the beginning?

Ioannis Dimarakis1, Nagy A Habib, Myrtle Y A Gordon.   

Abstract

Coronary artery disease leading to ischaemia of the human myocardium is one of the chief causes of morbidity and mortality in the western world. Cellular transplantation has recently been proposed as a novel alternative treatment modality. Adult bone marrow-derived autologous cells are one of the key cell types under investigation in both the experimental and clinical setting. A range of theories has been proposed with regard to the observed myocardial function improvement in both human and animal studies. A concerted interest in scientific questions needs to be constructed on the regenerative information made available throughout the last years. It is only now that we begin to fully understand this fast growing body of research and how it may have wide ranging implications for the treatment of ischemic heart disease.

Entities:  

Mesh:

Year:  2005        PMID: 16194607     DOI: 10.1016/j.ejcts.2005.08.013

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  3 in total

Review 1.  Heart repair and stem cells.

Authors:  Linda W van Laake; Rutger Hassink; Pieter A Doevendans; Christine Mummery
Journal:  J Physiol       Date:  2006-09-28       Impact factor: 5.182

Review 2.  Evaluation of the effectiveness of infusion of bone marrow derived cell in patients with heart failure: A network meta-analysis of randomized clinical trials and cohort studies.

Authors:  Farhad Lotfi; Mojtaba Jafari; Mohsen Rezaei Hemami; Mahmood Salesi; Shekoufeh Nikfar; Hossein Behnam Morshedi; Javad Kojuri; Khosro Keshavarz
Journal:  Med J Islam Repub Iran       Date:  2020-12-30

3.  Knowledge and attitudes towards stem cells and the significance of their medical application among healthcare sciences students of Jouf University.

Authors:  Abdulrahman Almaeen; Farooq Ahmed Wani; Ashokkumar Thirunavukkarasu
Journal:  PeerJ       Date:  2021-01-19       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.